SCHEMBL3086776

SCHEMBL3086776

Cc1ccc(-c2c3c(nn2Cc2ccccc2)CCCC3)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
LMNA P02545 3/20 0.45
POLB P06746 1/20 0.45
HTR2A P28223 2/20 0.45
HTR2C P28335 2/20 0.45
HTR2B P41595 2/20 0.45
CYP19A1 P11511 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
ALDH1A1 P00352 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3087986 0.88 NR1H2 (0.50) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL3070016 0.78 MEN1 (0.47) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL1476677 0.77 HTR2C (0.59) SMN1; SMN2MEN1KMT2AHTR2AHTR2C
SCHEMBL3075374 0.77 CYP19A1 (0.43) SMN1; SMN2NPC1RAB9ACYP1A2CYP3A4
SCHEMBL1476424 0.75 HTR2C (0.72) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL4494497 0.74 ALDH1A1 (0.53) SMN1; SMN2NPC1RAB9ACYP1A2CYP3A4
SCHEMBL1475046 0.74 HTR2A (0.65) HTR2AHTR2CHTR2BNR1H3NR1H2
SCHEMBL2073851 0.74 HTR7 (0.60) SMN1; SMN2LMNAHTR2AHTR2CHTR2B
SCHEMBL8025183 0.73 KDM4E (0.51) SMN1; SMN2NPC1RAB9ACYP1A2CYP3A4
SCHEMBL1475511 0.73 HTR2C (0.61) HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795294-B2 Tetrahydro-2H-indazole pyrazole cannabinoid modulators JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-14 US disclosed